Tobramycin Inhalation Powder in Cystic Fibrosis Patients: Response by Age Group

Respiratory Care- United States

doi 10.4187/respcare.02264

Full Text

Abstract

Available in

Categories

Respiratory Medicine

Intensive Care Medicine

Date

August 27, 2013

Authors

Publisher

Daedalus Enterprises

Related search

Safety, Efficacy and Convenience of Tobramycin Inhalation Powder in Cystic Fibrosis Patients: The EAGER Trial

Journal of Cystic Fibrosis

Respiratory Medicine

English

Home Videos of Cystic Fibrosis Patients Using Tobramycin Inhalation Powder: Relation of Flow and Cough

Pediatric Pulmonology

Respiratory Medicine

English

Bayesian Estimation of Tobramycin Exposure in Patients With Cystic Fibrosis

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Systematic Review of the Dry Powder Inhalers Colistimethate Sodium and Tobramycin in Cystic Fibrosis

European Respiratory Review

Respiratory Medicine

English

PIN107 Tobramycin Inhaled Solution Utilization by Cystic Fibrosis Patients: An Analysis With the RAMQ Database

Value in Health

Occupational Health

English

Efficiency of Pulmonary Administration of Tobramycin Solution for Inhalation in Cystic Fibrosis Using an Improved Drug Delivery System

Cardiovascular Medicine

Intensive Care Medicine

Respiratory Medicine

English

Development of Levofloxacin Inhalation Solution to Treat Pseudomonas Aeruginosa in Patients With Cystic Fibrosis

Therapeutic Advances in Respiratory Disease

Respiratory Medicine

English

In Vitro Activity of Amiloride Combined With Tobramycin Against Pseudomonas Isolates From Patients With Cystic Fibrosis.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Long-Term Inhaled Dry Powder Mannitol in Cystic Fibrosis

American Journal of Respiratory and Critical Care Medicine

Respiratory Medicine

Intensive Care Medicine

English